U.S. Electronic Equipment and Components Stock News

Ultra Clean Holdings (NasdaqGS:UCTT) announced that Clarence Granger will step down as Chairman of the Board effective May 22, 2026. Tom Edman has been appointed to assume the Chairman role as the company adjusts its leadership at the board and executive levels. This change follows a period of executive transitions while the sector is influenced by increased AI related investment. Ultra Clean Holdings, trading at $74.61, has seen sharp share price moves recently, including a 10.1% decline...

Relay Therapeutics (RLAY) has drawn fresh attention after deciding to advance zovegalisib plus Pfizer’s atirmociclib into Phase 3 for PI3Ka-mutated, HR+/HER2- metastatic breast cancer, following early safety and response data in heavily pre-treated patients. See our latest analysis for Relay Therapeutics. The share price has been volatile around the latest zovegalisib update, with a 7 day share price return of negative 15.9%, following a 90 day share price return of 66.1% and a 1 year total...

In April 2026, Range Resources reported first-quarter 2026 results showing daily production of about 1,508,842 Mcf of natural gas, 108,193 barrels of NGLs, 8,239 barrels of oil and total revenue of US$1,034.17 million, with net income of US$341.63 million and diluted EPS of US$1.44 from continuing operations. Alongside these stronger operational and financial results, new Schedule 13G filings reveal that Vanguard entities have built passive stakes above 5% of Range Resources’ outstanding...

In late April 2026, Johnson & Johnson reported strong first‑quarter results with revenue of US$24.06 billion, raised its full‑year sales outlook to US$100.30–US$101.30 billion, increased its quarterly dividend to US$1.34 per share, and advanced key therapies including IMAAVY (nipocalimab) receiving FDA Priority Review in warm autoimmune hemolytic anemia and CAPLYTA (lumateperone) gaining an expanded label for preventing schizophrenia relapse. These moves highlight Johnson & Johnson’s effort...

If you are wondering whether New Jersey Resources at around US$56 is offering good value today, it helps to step back and look at what the recent price and fundamentals are really telling you. The stock has recently closed at US$56, with returns of 0.3% over 7 days, 1.8% over 30 days, 21.8% year to date, 17.6% over 1 year, 23.4% over 3 years, and 54.5% over 5 years. This gives plenty of data points to weigh up how the market currently views its prospects and risks. Recent coverage around New...

Context for Helios Technologies after recent performance Helios Technologies (HLIO) has drawn renewed investor interest after a recent period where the stock showed mixed moves, with a 2.3% decline over the past week and a 2.2% decline over the past month. See our latest analysis for Helios Technologies. Despite the recent soft patch in the share price, with a 30 day share price return of a 2.18% decline, momentum over a longer window still reflects a 22.17% year to date share price gain and...

Granite Construction (GVA) is back in focus after Q1 2026 results showed stronger than expected revenue, a higher full year revenue outlook to US$5.2b to US$5.4b, and record backlog supported by acquisitions. See our latest analysis for Granite Construction. The stronger Q1 2026 update appears to have fed into the share price, with Granite Construction’s 7 day share price return of 13.01% and 30 day return of 13.98% adding to a 1 year total shareholder return of 72.64%. This suggests momentum...

If you are wondering whether Callaway Golf at around US$15.16 is still reasonably priced after its recent run, the valuation story is the key place to focus. The stock has seen sharp moves, with a 29.4% return year to date and 121.3% over the last year, set against a 32.1% decline over three years and a 51.3% decline over five years. These swings have kept Callaway Golf on many watchlists, as investors weigh shorter term momentum of 9.7% over the last 30 days against a 1% decline over the...

In April 2026, Medpace Holdings reported first-quarter 2026 results showing sales of US$706.6 million and net income of US$123.87 million, with both basic and diluted earnings per share rising year over year, and issued full-year 2026 guidance for revenue of US$2.76–2.86 billion and GAAP net income of US$487.0–511.0 million alongside President Jesse Geiger’s planned retirement. An interesting detail for investors is that Medpace’s full-year 2026 outlook assumes a 19–20% tax rate and US$27.5...

Fidelis Insurance Holdings (NYSE:FIHL) has entered into a major share repurchase agreement that ends founding shareholder CVC Falcon Holdings Limited's ownership stake. The company has also approved amendments to its Bye Laws at its latest annual meeting, signaling changes to its governance framework. These decisions mark a meaningful shift in ownership and corporate rules that is relevant for existing and prospective shareholders. Fidelis Insurance Holdings, a specialty insurance and...

If you are wondering whether Incyte's current share price still offers value or has already priced in recent enthusiasm, the next sections will walk through what the numbers actually say. Over the past year the stock has returned 55.0%, with shorter term moves of 2.4% over 7 days, 2.8% over 30 days and a year to date return of a 4.4% decline, which can change how the market views both its growth potential and its risks. Recent coverage has focused on Incyte's position in biotech and the...

Huntsman (HUN) opened 2026 with Q1 revenue of US$1.4 billion and a basic EPS loss of US$0.30, while the trailing twelve months show revenue of US$5.7 billion and a basic EPS loss of US$1.87. Over recent quarters, revenue has ranged between US$1.4 billion and US$1.5 billion, with quarterly basic EPS losses stretching from roughly US$0.02 to US$0.92. Investors are therefore looking at a business that is still working through margin pressure rather than expanding profitability. See our full...

Wondering if Teradyne at US$345.42 is priced for perfection or still offers value? This article breaks down what the current market price might be implying. The stock has seen sharp moves, with a 17.4% decline over the last 7 days, an 11.6% gain over 30 days, and returns of 66.4% year to date and 356.9% over the past year. Recent coverage of Teradyne has focused on its role in semiconductors and automation, and how investor interest in these themes has lined up with the share price moves...

Nutex Health (NUTX) is back on investors’ radar after Q1 2026 results showed net income more than doubling year over year, stronger EPS, and continued hospital expansion plans supported by its existing arbitration driven model. See our latest analysis for Nutex Health. That earnings surprise and expansion pipeline have coincided with a sharp rebound in the shares, with a 1 day share price return of 17.1%, 7 day share price return of 28.9% and 30 day share price return of 41.8%. The 1 year...

MaxLinear (NasdaqGS:MXL) introduced its Washington 200G per lane optical transimpedance amplifier for 1.6T AI data center interconnects. Samples of the new TIA are currently available to customers, with mass production targeted for the second half of 2026. The launch comes as the company reports upgraded sales targets and momentum in its optical business. For investors tracking AI infrastructure, this move places MaxLinear closer to the core of next generation data center build outs. The...

Kearny Financial Corp. ( NASDAQ:KRNY ) stock is about to trade ex-dividend in 3 days. Typically, the ex-dividend date...

Addus HomeCare Corporation ( NASDAQ:ADUS ), is not the largest company out there, but it received a lot of attention...

Some Texas Instruments Incorporated ( NASDAQ:TXN ) shareholders may be a little concerned to see that the Independent...

A week ago, Glaukos Corporation ( NYSE:GKOS ) came out with a strong set of first-quarter numbers that could...

Wondering whether FactSet Research Systems at around US$227.58 still reflects its true worth, or if the market has moved ahead of the fundamentals. The stock has risen 1.5% over the last 7 days and 1.2% over the last 30 days, although year to date it is down 20.1% and the 1 year return sits at a 46.9% loss. These moves come as investors reassess established financial data and analytics providers. FactSet Research Systems is often mentioned in discussions around long term demand for market...

Western Digital (WDC) has put up another big quarter, with Q2 2026 revenue at US$3.0b and basic EPS of US$5.27, backed by trailing twelve month revenue of US$10.7b and EPS of US$11.40 that reflect a very large year over year earnings swing. Over recent quarters, the company has seen revenue move from US$2.2b in Q1 2025 to US$3.0b in Q2 2026, while basic EPS has shifted from US$0.43 to US$5.27. This sets up a story where higher reported profitability, supported by a 36.8% trailing net margin...

The Gross Law Firm recently announced a class action lawsuit on behalf of Oddity Tech shareholders, alleging the company made materially false and misleading statements about digital advertising costs after an algorithm change by its largest advertising partner increased customer acquisition costs and hurt its business outlook. This legal challenge raises fresh questions about how dependent Oddity’s business model is on a single digital ad ecosystem and the transparency of its cost...

Entegris, Inc. ( NASDAQ:ENTG ) shareholders are probably feeling a little disappointed, since its shares fell 8.8% to...

Wondering if Revolve Group at around US$24.98 is giving you value or just volatility? This article breaks down what the current price might really represent. The stock has a mixed recent record, with a 12.5% gain over 30 days, a 6.9% pullback over the last week, a 27.9% return over 1 year and a 57.0% decline over 5 years. Recent coverage has focused on how Revolve Group fits within the broader U.S. retail space and how investors are reacting to changing consumer preferences and online...